Nexalis Therapeutics Limited (ASX:NX1)
Australia · Delayed Price · Currency is AUD
0.0250
0.00 (0.00%)
At close: Mar 3, 2026
Revenue by Segment
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
Development of Medical Technologies | | 401.81K | 1.20M | 24.80K | 181.74K | 22.13K | | | | |
Development of Medical Technologies Growth | | -66.63% | 4755.02% | -86.35% | 721.35% | -83.36% | | | | |
| | 401.81K | 1.20M | 24.80K | 181.74K | 22.13K | | | | |
| | -66.63% | 4755.02% | -86.35% | 721.35% | -83.36% | | | | |
Revenue by Geography
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | - | - | 24.80K | 167.30K | 12.56K | | | | |
| | - | - | -85.18% | 1232.33% | - | | | | |
| | - | - | 24.80K | 167.30K | 12.56K | | | | |
| | - | - | -85.18% | 1232.33% | -73.05% | | | | |
Source: S&P Global Market Intelligence.
